Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  HIV Infection

  Free Subscription

Articles published in J Immunol

Retrieve available abstracts of 34 articles:
HTML format

Single Articles

    October 2023
  1. KING HAD, Pokkali S, Kim D, Brammer D, et al
    Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques.
    J Immunol. 2023 Oct 20:ji2300424. doi: 10.4049/jimmunol.2300424.
    PubMed     Abstract available

    September 2023
  2. KAUR A, Surnilla A, Zaitouna AJ, Mumphrey MB, et al
    Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.
    J Immunol. 2023 Sep 22:ji2300232. doi: 10.4049/jimmunol.2300232.
    PubMed     Abstract available

    August 2023
  3. SANDBERG JK, Leeansyah E, Eller MA, Shacklett BL, et al
    The Emerging Role of MAIT Cell Responses in Viral Infections.
    J Immunol. 2023;211:511-517.
    PubMed     Abstract available

    June 2023
  4. CAMPBELL GR, Rawat P, To RK, Spector SA, et al
    HIV-1 Tat Upregulates TREM1 Expression in Human Microglia.
    J Immunol. 2023 Jun 16:ji2300152. doi: 10.4049/jimmunol.2300152.
    PubMed     Abstract available

    May 2023
  5. MAJUMDAR S, Pontejo SM, Jaiswal H, Gao JL, et al
    Severe CD8+ T Lymphopenia in WHIM Syndrome Caused by Selective Sequestration in Primary Immune Organs.
    J Immunol. 2023 May 3:ji2200871. doi: 10.4049/jimmunol.2200871.
    PubMed     Abstract available

  6. SCHROTER J, Borghans JAM, Bitter WM, van Dongen JJM, et al
    Age-Dependent Normalization Functions for T Lymphocytes in Healthy Individuals.
    J Immunol. 2023 May 1:ji2200520. doi: 10.4049/jimmunol.2200520.
    PubMed     Abstract available

    HIV Never Sleeps: Evidence to Support Early Antiretroviral Treatment.
    J Immunol. 2023;210:1181-1182.

    March 2023
  8. HEMANN EA, Knoll ML, Wilkins CR, Subra C, et al
    A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.
    J Immunol. 2023 Mar 20:ji2300026. doi: 10.4049/jimmunol.2300026.
    PubMed     Abstract available

    February 2023
  9. QUINN M, Parra-Rodriguez L, Alsoussi WB, Ayres C, et al
    Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination.
    J Immunol. 2023 Feb 13:ji2200920. doi: 10.4049/jimmunol.2200920.
    PubMed     Abstract available

    December 2022
  10. HANSAKON A, Ngamphiw C, Tongsima S, Angkasekwinai P, et al
    Arginase 1 Expression by Macrophages Promotes Cryptococcus neoformans Proliferation and Invasion into Brain Microvascular Endothelial Cells.
    J Immunol. 2022 Dec 21:ji2200592. doi: 10.4049/jimmunol.2200592.
    PubMed     Abstract available

    November 2022
  11. MARTINEZ LE, Ibarrondo J, Guo Y, Penichet ML, et al
    Follicular CD8+ T Cells Are Elevated in HIV Infection and Induce PD-L1 on B Cells.
    J Immunol. 2022 Nov 23:ji2200194. doi: 10.4049/jimmunol.2200194.
    PubMed     Abstract available

    October 2022
  12. SHOOK LL, Fourman LT, Edlow AG
    Immune Responses to SARS-CoV-2 in Pregnancy: Implications for the Health of the Next Generation.
    J Immunol. 2022;209:1465-1473.
    PubMed     Abstract available

    September 2022
  13. MA K, Chai Y, Guan J, Tan S, et al
    Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors.
    J Immunol. 2022 Sep 21. pii: jimmunol.2200191. doi: 10.4049/jimmunol.2200191.
    PubMed     Abstract available

  14. BELANGER S, Haupt S, Freeman BL, Getzler AJ, et al
    The Transcription Factor YY-1 Is an Essential Regulator of T Follicular Helper Cell Differentiation.
    J Immunol. 2022 Sep 12. pii: jimmunol.2101176. doi: 10.4049/jimmunol.2101176.
    PubMed     Abstract available

  15. ADDISON MM, Ellis GI, Leslie GJ, Zawadzky NB, et al
    HIV-1-Infected CD4(+) T Cells Present MHC Class II-Restricted Epitope via Endogenous Processing.
    J Immunol. 2022;209:864-873.
    PubMed     Abstract available

  16. NASSER H, Takahashi N, Eltalkhawy YM, Reda O, et al
    Inhibitory and Stimulatory Effects of IL-32 on HIV-1 Infection.
    J Immunol. 2022;209:970-978.
    PubMed     Abstract available

    July 2022
  17. KAZMIERSKI J, Elsner C, Dohner K, Xu S, et al
    A Baseline Cellular Antiviral State Is Maintained by cGAS and Its Most Frequent Naturally Occurring Variant rs610913.
    J Immunol. 2022 Jul 18. pii: jimmunol.2100685. doi: 10.4049/jimmunol.2100685.
    PubMed     Abstract available

  18. VOILLET V, Berger TR, McKenna KM, Paulson KG, et al
    An In Vivo Model of Human Macrophages in Metastatic Melanoma.
    J Immunol. 2022 Jul 11. pii: jimmunol.2101109. doi: 10.4049/jimmunol.2101109.
    PubMed     Abstract available

  19. COHEN KW, Tian Y, Thayer C, Seese A, et al
    Th2-Biased Transcriptional Profile Predicts HIV Envelope-Specific Polyfunctional CD4(+) T Cells That Correlated with Reduced Risk of Infection in RV144 Trial.
    J Immunol. 2022 Jul 8. pii: jimmunol.2101211. doi: 10.4049/jimmunol.2101211.
    PubMed     Abstract available

  20. MAKATSA MS, Omondi FMA, Bunjun R, Wilkinson RJ, et al
    Characterization of Mycobacterium tuberculosis-Specific Th22 Cells and the Effect of Tuberculosis Disease and HIV Coinfection.
    J Immunol. 2022 Jul 1. pii: jimmunol.2200140. doi: 10.4049/jimmunol.2200140.
    PubMed     Abstract available

    June 2022
  21. RAHMBERG AR, Markowitz TE, Mudd JC, Hirsch V, et al
    Epigenetic Reprogramming Leads to Downregulation of CD4 and Functional Changes in African Green Monkey Memory CD4(+) T Cells.
    J Immunol. 2022 Jun 24. pii: jimmunol.2200109. doi: 10.4049/jimmunol.2200109.
    PubMed     Abstract available

    CCR5: The Receptor That Unlocks the Door for HIV Entry into Cells.
    J Immunol. 2022;208:2459-2460.

    May 2022
  23. RICHERT L, Lelievre JD, Lacabaratz C, Hardel L, et al
    T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial.
    J Immunol. 2022 May 25. pii: jimmunol.2101076. doi: 10.4049/jimmunol.2101076.
    PubMed     Abstract available

  24. TARIQ M, Gallien S, Surenaud M, Wiedemann A, et al
    Profound Defect of Amphiregulin Secretion by Regulatory T Cells in the Gut of HIV-Treated Patients.
    J Immunol. 2022 May 2. pii: jimmunol.2100725. doi: 10.4049/jimmunol.2100725.
    PubMed     Abstract available

    March 2022
  25. XIE G, Moron-Lopez S, Siegel DA, Yin K, et al
    Common and Divergent Features of T Cells from Blood, Gut, and Genital Tract of Antiretroviral Therapy-Treated HIV(+) Women.
    J Immunol. 2022 Mar 16. pii: jimmunol.2101102. doi: 10.4049/jimmunol.2101102.
    PubMed     Abstract available

  26. CHRISTIAN ML, Dapp MJ, Scharffenberger SC, Jones H, et al
    CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory-like Cells.
    J Immunol. 2022 Mar 9. pii: jimmunol.2100491. doi: 10.4049/jimmunol.2100491.
    PubMed     Abstract available

    February 2022
  27. BOULOUIS C, Leeansyah E, Mairpady Shambat S, Norrby-Teglund A, et al
    Mucosa-Associated Invariant T Cell Hypersensitivity to Staphylococcus aureus Leukocidin ED and Its Modulation by Activation.
    J Immunol. 2022 Feb 9. pii: jimmunol.2100912. doi: 10.4049/jimmunol.2100912.
    PubMed     Abstract available

    January 2022
  28. KONING D, Quakkelaar ED, Schellens IMM, Spierings E, et al
    Protective HLA Alleles Recruit Biased and Largely Similar Antigen-Specific T Cell Repertoires across Different Outcomes in HIV Infection.
    J Immunol. 2022;208:3-15.
    PubMed     Abstract available

    December 2021
  29. BARRETT B, Nguyen DH, Xu J, Guo K, et al
    SAMHD1 Promotes the Antiretroviral Adaptive Immune Response in Mice Exposed to Lipopolysaccharide.
    J Immunol. 2021 Dec 10. pii: jimmunol.2001389. doi: 10.4049/jimmunol.2001389.
    PubMed     Abstract available

  30. CHIU CY, Chang JJ, Dantanarayana AI, Solomon A, et al
    Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.
    J Immunol. 2021 Dec 1. pii: jimmunol.2100367. doi: 10.4049/jimmunol.2100367.
    PubMed     Abstract available

    November 2021
  31. DZANIBE S, Lennard K, Kiravu A, Seabrook MSS, et al
    Stereotypic Expansion of T Regulatory and Th17 Cells during Infancy Is Disrupted by HIV Exposure and Gut Epithelial Damage.
    J Immunol. 2021 Nov 24. pii: jimmunol.2100503. doi: 10.4049/jimmunol.2100503.
    PubMed     Abstract available

  32. ABDULHAQQ S, Ventura AB, Reed JS, Bashirova AA, et al
    Identification and Characterization of Antigen-Specific CD8(+) T Cells Using Surface-Trapped TNF-alpha and Single-Cell Sequencing.
    J Immunol. 2021 Nov 22. pii: jimmunol.2100535. doi: 10.4049/jimmunol.2100535.
    PubMed     Abstract available

    October 2021
  33. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    PubMed     Abstract available

    June 2021

  34. Top Reads.
    J Immunol. 2021;206:2501.

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.